STOP Activators
The chemical class known as STOP Activators represents a group of compounds that exhibit a unique set of biological activities within cellular systems. These molecules are characterized by their ability to modulate specific cellular processes, particularly those associated with the regulation of cellular growth and division. STOP Activators are often involved in intricate signal transduction pathways, influencing key checkpoints in the cell cycle. Their molecular structures typically possess distinct functional groups that enable interactions with intracellular targets, ultimately leading to the modulation of cellular responses.
One notable feature of STOP Activators is their impact on the intricate balance between cell proliferation and cell cycle arrest. Through interactions with key proteins and signaling cascades, these compounds can exert control over the progression of the cell cycle, either promoting cell cycle arrest or facilitating continued cellular division. The intricate mechanisms through which STOP Activators operate underscore their significance in cellular homeostasis and underline for diverse applications in various biological contexts. Researchers are actively exploring the precise molecular interactions that govern the effects of STOP Activators, seeking a deeper understanding of their role in cellular regulation. As investigations into the intricacies of these compounds unfold, for uncovering novel insights into cellular biology and identifying new avenues for targeted interventions becomes increasingly promising.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rasagiline | 136236-51-6 | sc-204875 sc-204875A | 25 mg 100 mg | $101.00 $210.00 | ||
Rasagiline, a MAO-B inhibitor, influences the dopamine signaling pathway. By preventing the degradation of dopamine, it indirectly enhances STOP activation, as STOP is implicated in dopamine-related functions. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride enhances Wnt/β-catenin signaling. STOP is a downstream target of Wnt/β-catenin, and lithium chloride indirectly promotes STOP functional activity through the activation of this pathway. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a vitamin A derivative, modulates the retinoic acid signaling pathway. This impacts STOP directly, as STOP is a downstream effector of retinoic acid signaling, leading to enhanced STOP activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels. STOP is positively regulated by cAMP, and forskolin enhances STOP functional activity by upregulating cAMP, thereby influencing its downstream signaling. | ||||||
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
Bicuculline, a GABA-A receptor antagonist, influences the GABA signaling pathway. By blocking inhibitory GABAergic input, bicuculline indirectly enhances STOP activity, as STOP is modulated by GABAergic signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels. STOP is sensitive to calcium signaling, and A23187 enhances STOP activity by modulating calcium-dependent pathways that impact STOP function. | ||||||
Diosgenin | 512-04-9 | sc-205652 sc-205652B sc-205652A | 5 g 25 g 100 g | $47.00 $131.00 $517.00 | 4 | |
Diosgenin influences the PI3K/Akt signaling pathway. STOP is a downstream target of Akt, and diosgenin enhances STOP functional activity by activating the PI3K/Akt pathway, leading to the phosphorylation and activation of STOP. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine is a PKC inhibitor, affecting the PKC signaling pathway. STOP is regulated by PKC-mediated phosphorylation, and chelerythrine, by inhibiting PKC, indirectly enhances STOP functional activity through modulation of this pathway. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine activates the adenosine receptor, influencing the cAMP/PKA signaling pathway. STOP is modulated by cAMP, and adenosine enhances STOP activity by activating the cAMP/PKA pathway, leading to increased STOP functional activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting SERCA, affecting calcium signaling. STOP is sensitive to changes in calcium levels, and thapsigargin indirectly enhances STOP functional activity by perturbing calcium-dependent pathways. | ||||||